5-((1S,3R)-3-(4-(4-fluorophenyl)-1H-imidazol-2-yl)-1-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)nicotinicacid

ID: ALA3323085

Chembl Id: CHEMBL3323085

PubChem CID: 118710535

Max Phase: Preclinical

Molecular Formula: C30H24FN7O2

Molecular Weight: 533.57

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1cc([C@]2(c3cncc(C(=O)O)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1

Standard InChI:  InChI=1S/C30H24FN7O2/c1-38-16-20(14-34-38)30(19-10-18(29(39)40)12-32-13-19)27-23(22-4-2-3-5-24(22)35-27)11-25(37-30)28-33-15-26(36-28)17-6-8-21(31)9-7-17/h2-10,12-16,25,35,37H,11H2,1H3,(H,33,36)(H,39,40)/t25-,30+/m1/s1

Standard InChI Key:  SWKJCRBTZSASTH-RNAHPLFWSA-N

Alternative Forms

1. Parent:

   

   ALA3323085

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 533.57

Molecular Weight (Monoisotopic): 533.1976

AlogP: 4.70

#Rotatable Bonds: 5

Polar Surface Area: 124.51

Molecular Species: ACID

HBA: 6

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.24

CX Basic pKa: 5.35

CX LogP: 2.32

CX LogD: 0.73

Aromatic Rings: 6

Heavy Atoms: 40

QED Weighted: 0.25

Np Likeness Score: -0.66

References

1. He S, Lai Z, Ye Z, Dobbelaar PH, Shah SK, Truong Q, Du W, Guo L, Liu J, Jian T, Qi H, Bakshi RK, Hong Q, Dellureficio J, Reibarkh M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang B, Howard AD, Zhou YP, Nargund RP, Hagmann WK..  (2014)  Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.,  5  (7): [PMID:25050159] [10.1021/ml500028c]

Source

Source(1):

• Scientific Literature